These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6197420)

  • 1. Abnormal behavior of cultured fibroblasts from nodule and nonaffected aponeurosis of Dupuytren's disease.
    Azzarone B; Failly-Crepin C; Daya-Grosjean L; Chaponnier C; Gabbiani G
    J Cell Physiol; 1983 Dec; 117(3):353-61. PubMed ID: 6197420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in alpha smooth muscle actin expression between fibroblasts derived from Dupuytren's nodules or cords.
    Dave SA; Banducci DR; Graham WP; Allison GM; Ehrlich HP
    Exp Mol Pathol; 2001 Oct; 71(2):147-55. PubMed ID: 11599921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dupuytren's disease: comparative growth dynamics and morphology between cultured myofibroblasts (nodule) and fibroblasts (cord).
    Vande Berg JS; Gelberman RH; Rudolph R; Johnson D; Sicurello P
    J Orthop Res; 1984; 2(3):247-56. PubMed ID: 6491814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palmar fascial complex anatomy and pathology in Dupuytren's disease.
    Rayan GM
    Hand Clin; 1999 Feb; 15(1):73-86, vi-vii. PubMed ID: 10050244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta1 stimulation enhances Dupuytren's fibroblast contraction in response to uniaxial mechanical load within a 3-dimensional collagen gel.
    Bisson MA; Beckett KS; McGrouther DA; Grobbelaar AO; Mudera V
    J Hand Surg Am; 2009; 34(6):1102-10. PubMed ID: 19505772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The myofibroblast in Dupuytren's contracture.
    Rudolph R; Vande Berg J
    Hand Clin; 1991 Nov; 7(4):683-92; discussion 693-4. PubMed ID: 1769990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
    Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
    J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine manipulation of explanted Dupuytren's affected human palmar fascia.
    Kuhn MA; Payne WG; Kierney PC; Pu LL; Smith PD; Siegler K; Ko F; Wang X; Robson MC
    Int J Surg Investig; 2001; 2(6):443-56. PubMed ID: 12678125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of steroids on Dupuytren's disease: role of programmed cell death.
    Meek RM; McLellan S; Reilly J; Crossan JF
    J Hand Surg Br; 2002 Jun; 27(3):270-3. PubMed ID: 12074617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin filaments and actin microfilaments are organized into a fibronexus in Dupuytren's diseased tissue.
    Tomasek JJ; Haaksma CJ
    Anat Rec; 1991 Jun; 230(2):175-82. PubMed ID: 1867394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular actin as a marker for myofibroblasts in vitro.
    Foo IT; Naylor IL; Timmons MJ; Trejdosiewicz LK
    Lab Invest; 1992 Dec; 67(6):727-33. PubMed ID: 1460863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
    Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
    J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopathological study on palmar aponeurosis in Dupuytren's disease.
    Józsa L; Demel S; Pintér T; Renner A; Réffy A; Sántha A; Salamon A
    Acta Histochem; 1988; 83(2):153-8. PubMed ID: 3138883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell behavior and cell-matrix interactions of human palmar aponeurotic cells in vitro.
    Quaglino D; Bergamini G; Croce A; Boraldi F; Barbieri D; Caroli A; Marcuzzi A; Tiozzo R; Ronchetti IP
    J Cell Physiol; 1997 Dec; 173(3):415-22. PubMed ID: 9369955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor (EGF-R) in Dupuytren's disease.
    Augoff K; Taboła R; Kula J; Gosk J; Rutowski R
    J Hand Surg Br; 2005 Dec; 30(6):570-3. PubMed ID: 16055243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of an MMP inhibitor in the regulation of mechanical tension by Dupuytren's disease fibroblasts.
    Townley WA; Cambrey AD; Khaw PT; Grobbelaar AO
    J Hand Surg Eur Vol; 2009 Dec; 34(6):783-7. PubMed ID: 19786408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Dupuytren's disease caused by an imbalance between proliferation and cell death?
    Jemec B; Grobbelaar AO; Wilson GD; Smith PJ; Sanders R; McGrouther DA
    J Hand Surg Br; 1999 Oct; 24(5):511-4. PubMed ID: 10597921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptors in Dupuytren's contracture.
    Pagnotta A; Specchia N; Greco F
    J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of myofibroblasts in the pathogenesis of Dupuytren's contracture].
    Salamon A; Hámori J
    Handchirurgie; 1980; 12(1-2):113-7. PubMed ID: 7195866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dupuytren's disease: physiologic changes in nodule and cord fibroblasts through aging in vitro.
    Moyer KE; Banducci DR; Graham WP; Ehrlich HP
    Plast Reconstr Surg; 2002 Jul; 110(1):187-93; discussion 194-6. PubMed ID: 12087251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.